|
|
Volumn 354, Issue 18, 2006, Pages 1869-1871
|
|
Injury to research volunteers - The clinical-research nightmare
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HISTAMINE H2 RECEPTOR ANTAGONIST;
MONOCLONAL ANTIBODY CD28;
TGN 1412;
CYTOKINE;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY TGN1412;
AUTOIMMUNE DISEASE;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL PRACTICE;
CLINICAL RESEARCH;
CLINICAL TRIAL;
CYTOKINE RELEASE SYNDROME;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG SAFETY;
HEALTH CARE ORGANIZATION;
HEART ARRHYTHMIA;
HUMAN;
LEUKOPENIA;
LIVER INJURY;
MULTIPLE ORGAN FAILURE;
MULTIPLE SCLEROSIS;
PATIENT SAFETY;
PRIORITY JOURNAL;
PROFESSIONAL STANDARD;
RASH;
RESEARCH ETHICS;
RESEARCH SUBJECT;
RHEUMATOID ARTHRITIS;
RISK BENEFIT ANALYSIS;
SHORT SURVEY;
SYNDROME;
VOLUNTEER;
ARTICLE;
DRUG INDUSTRY;
DRUG SCREENING;
HUMAN EXPERIMENT;
MALE;
METABOLISM;
PHASE 1 CLINICAL TRIAL;
ANTIBODIES, MONOCLONAL;
CLINICAL TRIALS, PHASE I;
CYTOKINES;
DRUG EVALUATION;
DRUG INDUSTRY;
HUMAN EXPERIMENTATION;
HUMANS;
MALE;
RESEARCH SUBJECTS;
|
|
EID: 33646379402
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMp068082 Document Type: Short Survey |
|
Times cited : (47)
|
|
References (5)
|
